Home > Healthcare > Medical Devices > Medical Supplies > Capillary Blood Collection Devices Market

Capillary Blood Collection Devices Market Trends

Report ID: GMI8035
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Capillary Blood Collection Devices Market Trends

The growing emphasis on point of care testing (POCT) represents a significant trend in the healthcare industry, with notable implications for the demand and utilization of capillary blood collection devices. Point-of-care testing involves conducting diagnostic tests at or near the location where patient care is provided, rather than sending samples to a centralized laboratory. This shift towards decentralized testing has been facilitated by advancements in technology and has several key implications.

Point-of-care testing allows for the generation of rapid and immediate test results. Capillary blood collection devices play a crucial role in this process by providing a quick and convenient method for obtaining blood samples at the point of care. This immediacy is particularly valuable in emergency situations and for time-sensitive medical decisions.
Point-of-care testing, often utilizing capillary blood samples, brings diagnostics closer to patients, improving accessibility to healthcare services. This is particularly beneficial in remote or resource-limited settings where access to centralized laboratories may be challenging.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global capillary blood collection devices industry was valued at around USD 1.8 Billion in 2023 and is estimated to reach over USD 3.4 Billion by 2032, owing to the increasing prevalence of chronic diseases.

The plastic segment accounted for a revenue share of 59.4% in 2023 and is estimated to follow similar trend over the coming years, driven by ongoing advancements in plastic materials, such as new formulations of polypropylene.

North America capillary blood collection devices market accounted for USD 798.7 million in 2023, attributed to aging population and the prevalence of chronic diseases.

Abbott Laboratories, Terumo Corporation, Becton, Dickinson and Company, Siemens Healthineers, Cardinal Health, Sarstedt AG & Co., Greiner Bio-One International GmbH, Roche Diagnostics, Medtronic plc, and Radiometer Medical ApS.